Amarin | AMRN - Trade Debtors


Amarin reported $126.83M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amarin USD 126.83M 477K Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
DBV Technologies USD 15.97M 279K Sep/2025
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025